A Practical Guide for Primary Care Providers on Timely Diagnosis and Comprehensive Care Strategies for Hidradenitis Suppurativa - 05/12/22
, Haley B. Naik, MD, MHSc b, Joslyn S. Kirby, MD, MS, MEd cAbstract |
Hidradenitis suppurativa is a chronic, progressive inflammatory disease of the skin with many systemic implications. Hidradenitis suppurativa is frequently underdiagnosed or misdiagnosed, particularly because of heterogeneity in presentation and low disease recognition. Patients can see multiple types of health care providers, including primary care providers, along their journey to an accurate diagnosis. This review provides a comprehensive overview of the clinical presentation, associated comorbidities, and life impact associated with hidradenitis suppurativa. Disease features described here can facilitate earlier identification of hidradenitis suppurativa, differentiation from common mimickers, and timely referrals for multidisciplinary management when needed. Engagement of the medical community will also support comprehensive care strategies necessary in hidradenitis suppurativa.
El texto completo de este artículo está disponible en PDF.Keywords : Hidradenitis suppurativa, HS clinical presentation, HS management, Primary care provider
Esquema
| Funding: Support for third-party writing assistance for this manuscript was provided by Novartis. |
|
| Conflicts of Interest: AG has served as an advisor and/or received honoraria from AbbVie, Aclaris Therapeutics, AnaptysBio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Meyers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB, and Viela Biosciences; has received research grants from AbbVie, UCB, and National Psoriasis Foundation; and is co-copyright holder of the Hidradenitis Suppurativa Investigator Global Assessment and Hidradenitis Suppurativa Quality of Life instruments. HBN has received consulting fees from 23andMe, AbbVie, Aristea Therapeutics, DAVA Oncology, and Nimbus Therapeutics; advisory fees from Boehringer Ingelheim; investigator fees from Pfizer; grant support from AbbVie; serves as an associate editor for JAMA Dermatology; and is a board member of the US Hidradenitis Suppurativa Foundation. JSK has received speaker and consultant fees from AbbVie; consultant fees from ChemoCentryx, Incyte, Janssen, Novartis, and UCB; and grant support from Incyte. |
|
| Authorship: All authors made substantial contributions to the conception and methodology of this literature review; were involved in drafting and critically revising the manuscript; have given necessary attention to ensure the integrity of the work; and have read and approved all versions of this manuscript and its submission. |
Vol 136 - N° 1
P. 42-53 - janvier 2023 Regresar al número
Artículo precedente
- Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations
- Joseph Mikhael, Manisha Bhutani, Craig E. Cole
- Heliotrope Rash, Gottron Papules, and Ragged Cuticles in Darker Skin
- Mark C. Marchitto, Isabelle D. Brown, Jaroslaw Jedrych, Sima Rozati
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?